M SD has announced positive Phase III HYPERION trial results showing Winrevair (sotatercept-csrk) reduced clinical worsening ...

Patients had less clinical worsening when treated with this “wonder drug,” as one doctor called it, within a year of ...

Kaplan-Meier analyses show for the first time that median Overall Survival exceeds 25 months for Platinum Resistant and ...

Consuming a diverse diet during pregnancy may reduce the risk for atopic dermatitis in offspring by changing the infant gut ...

Therapeutics, a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib, a differentiated, dual PARP and ...

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive results from the Phase 3 ...

Combination therapy with relatlimab and nivolumab enhances treatment-free survival in advanced melanoma, offering promising ...

Melanoma in pregnancy and postpartum is not associated with worse outcomes compared with melanoma in women who are not pregnant.

Taiwan: Patients with hidradenitis suppurativa (HS) face a significantly higher risk of developing peripheral arterial ...

At a live event in White Plains, New York, Adriana Rossi, MD, assistant professor of medicine and director of CAR T and the Stem Cell Transplant Clinical Service at the Center of Excellence for ...